HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally. The company's lead products include Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 647 495 9000
Fax: 416 213 0045
Address:
10 Carlson Court, Suite 701, Etobicoke, Canada
